Optomed - Terveysteknologiayhtiö

Lisää näyttöä AI:n käytön hyödyistä diabeettisen retinopatian seulonnassa, tällä kertaa Omanista. Jossain vaiheessa vain takapajuiset terveydenhuollon organisaatiot jättävät AI:n hyödyntämättä.
..

Key Takeaways

  • Oman’s national AI diabetic retinopathy screening programme has screened over 43,000 patients across 25 health facilities in its first phase, according to Times of Oman.
  • The AI system has flagged more than 12,000 high-risk cases and operates at a reported 91.3 percent diagnostic accuracy rate.
  • Clinic wait times for eye assessments have dropped 87 percent, from 62 days to just 8 days, and diagnostic time per patient has fallen from over an hour to roughly 15 minutes.
  • Operational costs for the screening pathway are down 43.2 percent, freeing up specialists to focus on complex cases.
  • The Ministry of Health, through its National Center for Virtual Health, plans to extend the programme to remote areas, add glaucoma and keratoconus detection, and build a locally trained AI model using Omani patient data.
    ..
    43,000 Screened: Oman's AI Eye Tool Cuts Wait Times 87% - AI in Oman
18 tykkäystä